JPS6115875B2 - - Google Patents
Info
- Publication number
- JPS6115875B2 JPS6115875B2 JP53052249A JP5224978A JPS6115875B2 JP S6115875 B2 JPS6115875 B2 JP S6115875B2 JP 53052249 A JP53052249 A JP 53052249A JP 5224978 A JP5224978 A JP 5224978A JP S6115875 B2 JPS6115875 B2 JP S6115875B2
- Authority
- JP
- Japan
- Prior art keywords
- naphthyridine
- compound
- acid
- formula
- naphthyridines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 31
- 150000003839 salts Chemical class 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 6
- 101150009274 nhr-1 gene Proteins 0.000 claims description 2
- 150000005054 naphthyridines Chemical class 0.000 description 18
- -1 hydrogen halides Chemical class 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- 229910052739 hydrogen Inorganic materials 0.000 description 8
- 239000001257 hydrogen Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000003276 anti-hypertensive effect Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 6
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 6
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 5
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 239000002876 beta blocker Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 2
- HUWKQMRNPHUGMK-UHFFFAOYSA-N 2-oxo-1h-1,8-naphthyridine-3-carbonitrile Chemical compound C1=CC=C2C=C(C#N)C(O)=NC2=N1 HUWKQMRNPHUGMK-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N Furaldehyde Natural products O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 229940030611 beta-adrenergic blocking agent Drugs 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000002917 oxazolidines Chemical class 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UPUSBBKJEKFTLM-UHFFFAOYSA-N 1,3-oxazolidin-2-ylmethanol Chemical compound OCC1NCCO1 UPUSBBKJEKFTLM-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- VSOSXKMEQPYESP-UHFFFAOYSA-N 1,6-naphthyridine Chemical compound C1=CN=CC2=CC=CN=C21 VSOSXKMEQPYESP-UHFFFAOYSA-N 0.000 description 1
- UIQLQYQMGHYABX-UHFFFAOYSA-N 1-chloro-2,7-naphthyridine Chemical compound C1=NC=C2C(Cl)=NC=CC2=C1 UIQLQYQMGHYABX-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- TVQXOIIFUHIUDN-ZDUSSCGKSA-N 2-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-1,6-naphthyridine-3-carbonitrile Chemical compound C(#N)C=1C(=NC2=CC=NC=C2C=1)OC[C@H](CNC(C)(C)C)O TVQXOIIFUHIUDN-ZDUSSCGKSA-N 0.000 description 1
- JHHIUJRASOGQNH-ZDUSSCGKSA-N 2-[(2s)-3-(tert-butylamino)-2-hydroxypropoxy]-1,8-naphthyridine-3-carbonitrile Chemical compound C1=CC=C2C=C(C#N)C(OC[C@@H](O)CNC(C)(C)C)=NC2=N1 JHHIUJRASOGQNH-ZDUSSCGKSA-N 0.000 description 1
- FDRHWYNVFRNFCG-UHFFFAOYSA-N 2-chloro-1,6-naphthyridine-3-carbonitrile Chemical compound C1=NC=C2C=C(C#N)C(Cl)=NC2=C1 FDRHWYNVFRNFCG-UHFFFAOYSA-N 0.000 description 1
- ZYJZXWCCYCCBIB-UHFFFAOYSA-N 2-chloro-1,8-naphthyridine-3-carbonitrile Chemical compound C1=CC=C2C=C(C#N)C(Cl)=NC2=N1 ZYJZXWCCYCCBIB-UHFFFAOYSA-N 0.000 description 1
- FWWOWPGPERBCNJ-UHFFFAOYSA-N 2-hydroxy-4-(2-hydroxyethoxy)-4-oxobutanoic acid Chemical compound OCCOC(=O)CC(O)C(O)=O FWWOWPGPERBCNJ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ISDBWOPVZKNQDW-UHFFFAOYSA-N 4-phenylbenzaldehyde Chemical compound C1=CC(C=O)=CC=C1C1=CC=CC=C1 ISDBWOPVZKNQDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- YYAMQRMDGHGLDW-ABLWVSNPSA-N [(2s)-3-(tert-butylamino)-2-phenyl-1,3-oxazolidin-5-yl]methanol Chemical compound CC(C)(C)NN1CC(CO)O[C@H]1C1=CC=CC=C1 YYAMQRMDGHGLDW-ABLWVSNPSA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 239000000464 adrenergic agent Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000007883 bronchodilation Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940045996 isethionic acid Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 150000004002 naphthaldehydes Chemical class 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- JUKPJGZUFHCZQI-UHFFFAOYSA-N undecanoyl chloride Chemical compound CCCCCCCCCCC(Cl)=O JUKPJGZUFHCZQI-UHFFFAOYSA-N 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00Â -Â C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00Â -Â C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
æ¬çºæã¯æçšãªè¬ç©æŽ»æ§ãæããæ°èŠãªïŒâã¢
ããâïŒâORâããããã·çœ®æããããªãžã³ã«
é¢ãããã®ã§ããã βâã¢ãã¬ããªã³æ§é®æ掻æ§ãæããâãã
ãåç°åŒïŒâã¢ããâïŒâããããã·ããããã·
眮æååç©ã¯å ¬ç¥ã§ããïŒç±³åœç¹èš±ç¬¬4000282
å·ïŒåã¢ããªã«ç¹èš±ç¬¬74ïŒ01070å·ïŒãβâã¢ãã¬
ããªã³æ§é®ææå¹æ§ã瀺ãã¢ãââãããäºç°
åŒïŒâã¢ããâïŒâããããã·ããããã·çœ®æå
åç©ã¯å ¬ç¥ã§ãããã¯ã©ãŠã¶ãŒçãJ.Med.Chem.
第15å·»ã第260ã266é ïŒ1972幎ïŒã æ°èŠãªãžââãããäºç°åŒååç©ãèšæãã
ã°ïŒâã¢ããâïŒâORâããããã·ããããªãž
ã³ãé瀺ããããååç©ã¯Î²âã¢ãã¬ããªã³æ§é®
æ掻æ§ããã³çŽæ¥åæã®æé«è¡å§æŽ»æ§ãæããã å ·äœçã«ã¯æ¬çºæã¯åŒ ãŸã㯠ãæããååç©ããã³ãã®è£œè¬äžèªããããå¡©
ãåŒäžãã¯âCH2âCHOHâCH2âNHR1ïŒåŒäž
R1ã¯C1âC12ã¢ã«ãã«ã§ãããïŒã§ããããã§ã
ãã ããããªãžã³åŒâå ã®æ°ã¯ç°ã®äœçœ®ã瀺
ãã 補è¬äžèªããããå¡©ã¯ããããªãžã³éé¢å¡©åºã®
é žä»å å¡©ã§ããã奜é©ãªé žã¯ææ©äžŠã³ã«ç¡æ©é žã
å å«ããã䜿çšãããææ©é žã®å ·äœäŸã¯é ¢é žãã
ã¢ã€ãã¯ã¢ã·ããããã¬ã€ã³é žãã³ãã¯é žãã¯ãš
ã³é žãé ç³é žãã·ãŠãŠé žããªã³ãŽé žãããã«é žã
ãšãã³ãé žãã©ãŠãªã³é žãããããªã³é žããã©ã«
ãŽã³é žããªã¬ã€ã³é žçã®ã«ã«ãã³é žããã³ã€ã»ã
ãªã³é žã®ãããªéã«ã«ãã³é žã§ããã䜿çšããã
ç¡æ©é žã®å ·äœäŸã¯ããã²ã³åæ°ŽçŽ å³ã¡HClã
HBrãHIããªã³é žãç¡«é žçã§ãããããã²ã³å
æ°ŽçŽ å¡©ãç¹ã«å¡©åæ°ŽçŽ ããã³ãã¬ã€ã³é žç¹ã«ãã¬
ã€ã³é žæ°ŽçŽ å¡©ã奜ãŸããã R1眮æåºã¯C1âC12ã¢ã«ãã«åºãå å«ãC1âC6
ã¢ã«ãã«åºã奜ãŸãããã¢ã«ãã«åºã®å ·äœäŸã¯ã¡
ãã«ãC12H25âãããã·ã«ãïŒâãšãã«ããã·
ã«ãã€ãœãããã«ãsecâããã«ããããã«çã§
ãããC3-4åæéã¢ã«ãã«R1åºãããã«å¥œãŸã
ããïœâããã«ã¯éåžžã«å¥œãŸããã ããããªãžã³ååç©ã¯å åŠç掻æ§ãäžããäžã€
ã®ãã©ã«ïŒchiralïŒäžå¿ãæãããå åŠç°æ§äœã¯
é垞ããã³ïŒ€ãïœããã³ïœãïŒããã³âãã
ãã³ïŒ²ãšããŠãŸãã¯ãããã®èšå·ã®çµã¿åããã«
ãã€ãŠæ瀺ããããããã«ãããŠåŒãŸãã¯ååç©
ã®ååãç¹å®ã®èšå·ãæã€ãŠããªãåŒãŸãã¯åå
ç©ã¯åã ã®ç°æ§äœããã®æ··åäœããã³ã©ã»ãåå
ç©ãå å«ããã 奜ãŸããããããªãžã³é¡ã¯ç°ã®çªçŽ ã«å¯ŸããŠãª
ã«ãäœã«âOZåºãæãããã®ã§ããã ããã«å¥œãŸããããããªãžã³é¡ã«ãããŠã¯R2
眮æäœã¯ãŸãâOZåºã«å¯ŸããŠãªã«ãã§ããã ããã«å¥œãŸããããããªãžã³é¡ã¯åŒïŒ ãŸã㯠ãæããã æã奜ãŸããããããªãžã³ã«ãããŠã¯R2ã¯ã·
ã¢ãã§ããã¯âCH2âCHOHâCH2âNHR1ã§
R1ã¯C1âC6ã¢ã«ãã«ã§å¥œãŸããåºãšããŠã¯C3â
C4åæã¢ã«ãã«ã§å€§æµå¥œãŸããã¯ïœâããã«ã
æããŠããã ããããªãžã³é¡ã¯ãã¹ãŠå åŠç°æ§äœããã³æ··å
äœãå å«ãããâç°æ§äœã®åœ¢ã奜ãŸããã æ¬çºæã®ããããªãžã³é¡ã¯ãããã奜éœåãªæ¹
æ³ã«ãã€ãŠè£œé ããããšãã§ããã ãããæ¹æ³ã®äžã€ã¯ããããããªãžã³ãšå¥œé©ãª
眮æãªããµãŸãªãžã³ãšã®ã«ãããªã³ã°ãšåŸããã
åå¿çæç©ã®å æ°Žå解ãå å«ããããã®æ¹æ³ã¯æ¬¡
ã®åå¿åŒã«ãã€ãŠèª¬æãããã ããã¯ClãBrããã³ïŒ©ã§ããããšãã§ããã
Clã§ããããšã奜ãŸãããïŒã¯ã¢ã«ã«ãªéå±ã§
ãããã«ãªãŠã ãŸãã¯ãããªãŠã ã奜ãŸããã
Râ²ã¯æ°ŽçŽ ãŸãã¯ãããã奜é©ãªã¢ã«ããã
ããâïŒâORâããããã·çœ®æããããªãžã³ã«
é¢ãããã®ã§ããã βâã¢ãã¬ããªã³æ§é®æ掻æ§ãæããâãã
ãåç°åŒïŒâã¢ããâïŒâããããã·ããããã·
眮æååç©ã¯å ¬ç¥ã§ããïŒç±³åœç¹èš±ç¬¬4000282
å·ïŒåã¢ããªã«ç¹èš±ç¬¬74ïŒ01070å·ïŒãβâã¢ãã¬
ããªã³æ§é®ææå¹æ§ã瀺ãã¢ãââãããäºç°
åŒïŒâã¢ããâïŒâããããã·ããããã·çœ®æå
åç©ã¯å ¬ç¥ã§ãããã¯ã©ãŠã¶ãŒçãJ.Med.Chem.
第15å·»ã第260ã266é ïŒ1972幎ïŒã æ°èŠãªãžââãããäºç°åŒååç©ãèšæãã
ã°ïŒâã¢ããâïŒâORâããããã·ããããªãž
ã³ãé瀺ããããååç©ã¯Î²âã¢ãã¬ããªã³æ§é®
æ掻æ§ããã³çŽæ¥åæã®æé«è¡å§æŽ»æ§ãæããã å ·äœçã«ã¯æ¬çºæã¯åŒ ãŸã㯠ãæããååç©ããã³ãã®è£œè¬äžèªããããå¡©
ãåŒäžãã¯âCH2âCHOHâCH2âNHR1ïŒåŒäž
R1ã¯C1âC12ã¢ã«ãã«ã§ãããïŒã§ããããã§ã
ãã ããããªãžã³åŒâå ã®æ°ã¯ç°ã®äœçœ®ã瀺
ãã 補è¬äžèªããããå¡©ã¯ããããªãžã³éé¢å¡©åºã®
é žä»å å¡©ã§ããã奜é©ãªé žã¯ææ©äžŠã³ã«ç¡æ©é žã
å å«ããã䜿çšãããææ©é žã®å ·äœäŸã¯é ¢é žãã
ã¢ã€ãã¯ã¢ã·ããããã¬ã€ã³é žãã³ãã¯é žãã¯ãš
ã³é žãé ç³é žãã·ãŠãŠé žããªã³ãŽé žãããã«é žã
ãšãã³ãé žãã©ãŠãªã³é žãããããªã³é žããã©ã«
ãŽã³é žããªã¬ã€ã³é žçã®ã«ã«ãã³é žããã³ã€ã»ã
ãªã³é žã®ãããªéã«ã«ãã³é žã§ããã䜿çšããã
ç¡æ©é žã®å ·äœäŸã¯ããã²ã³åæ°ŽçŽ å³ã¡HClã
HBrãHIããªã³é žãç¡«é žçã§ãããããã²ã³å
æ°ŽçŽ å¡©ãç¹ã«å¡©åæ°ŽçŽ ããã³ãã¬ã€ã³é žç¹ã«ãã¬
ã€ã³é žæ°ŽçŽ å¡©ã奜ãŸããã R1眮æåºã¯C1âC12ã¢ã«ãã«åºãå å«ãC1âC6
ã¢ã«ãã«åºã奜ãŸãããã¢ã«ãã«åºã®å ·äœäŸã¯ã¡
ãã«ãC12H25âãããã·ã«ãïŒâãšãã«ããã·
ã«ãã€ãœãããã«ãsecâããã«ããããã«çã§
ãããC3-4åæéã¢ã«ãã«R1åºãããã«å¥œãŸã
ããïœâããã«ã¯éåžžã«å¥œãŸããã ããããªãžã³ååç©ã¯å åŠç掻æ§ãäžããäžã€
ã®ãã©ã«ïŒchiralïŒäžå¿ãæãããå åŠç°æ§äœã¯
é垞ããã³ïŒ€ãïœããã³ïœãïŒããã³âãã
ãã³ïŒ²ãšããŠãŸãã¯ãããã®èšå·ã®çµã¿åããã«
ãã€ãŠæ瀺ããããããã«ãããŠåŒãŸãã¯ååç©
ã®ååãç¹å®ã®èšå·ãæã€ãŠããªãåŒãŸãã¯åå
ç©ã¯åã ã®ç°æ§äœããã®æ··åäœããã³ã©ã»ãåå
ç©ãå å«ããã 奜ãŸããããããªãžã³é¡ã¯ç°ã®çªçŽ ã«å¯ŸããŠãª
ã«ãäœã«âOZåºãæãããã®ã§ããã ããã«å¥œãŸããããããªãžã³é¡ã«ãããŠã¯R2
眮æäœã¯ãŸãâOZåºã«å¯ŸããŠãªã«ãã§ããã ããã«å¥œãŸããããããªãžã³é¡ã¯åŒïŒ ãŸã㯠ãæããã æã奜ãŸããããããªãžã³ã«ãããŠã¯R2ã¯ã·
ã¢ãã§ããã¯âCH2âCHOHâCH2âNHR1ã§
R1ã¯C1âC6ã¢ã«ãã«ã§å¥œãŸããåºãšããŠã¯C3â
C4åæã¢ã«ãã«ã§å€§æµå¥œãŸããã¯ïœâããã«ã
æããŠããã ããããªãžã³é¡ã¯ãã¹ãŠå åŠç°æ§äœããã³æ··å
äœãå å«ãããâç°æ§äœã®åœ¢ã奜ãŸããã æ¬çºæã®ããããªãžã³é¡ã¯ãããã奜éœåãªæ¹
æ³ã«ãã€ãŠè£œé ããããšãã§ããã ãããæ¹æ³ã®äžã€ã¯ããããããªãžã³ãšå¥œé©ãª
眮æãªããµãŸãªãžã³ãšã®ã«ãããªã³ã°ãšåŸããã
åå¿çæç©ã®å æ°Žå解ãå å«ããããã®æ¹æ³ã¯æ¬¡
ã®åå¿åŒã«ãã€ãŠèª¬æãããã ããã¯ClãBrããã³ïŒ©ã§ããããšãã§ããã
Clã§ããããšã奜ãŸãããïŒã¯ã¢ã«ã«ãªéå±ã§
ãããã«ãªãŠã ãŸãã¯ãããªãŠã ã奜ãŸããã
Râ²ã¯æ°ŽçŽ ãŸãã¯ãããã奜é©ãªã¢ã«ããã
ãåŒãäŸãã°ãã³ãã¢ã«ãããããããã¢
ã«ããããïœâNO2âãã³ãã¢ã«ããããïœâã
ãšãã«ãã³ãã¢ã«ãããããã«ã¢ã«ãããçã®
C6âC12ã¢ãªãŒã«ã¢ã«ãããããã«ãã©ãŒã«ãŸã
ã¯ã¢ã»ãã¢ã«ããããããã«ã¢ã«ãããã
ãšãã«ãã³ãã¢ã«ãããããã«ã¢ã«ãããçã®
C6âC12ã¢ãªãŒã«ã¢ã«ãããããã«ãã©ãŒã«ãŸã
ã¯ã¢ã»ãã¢ã«ããããããã«ã¢ã«ãããã
ãåŒãïŒâãšãã«âãããµããŒã«çã®
ãããªC2âC12ã¢ã«ã«ããŒã«ã®ã¢ã«ãã«ãŸãã¯ã¢
ãªãŒã«æ®åºã§ãããïŒãæ°ŽçŽ ã§ãããªããµãŸãªãž
ã³é¡ã補é ããæ¹æ³ïŒããã³é¢é£ããã«ãããªã³
ã°åå¿ïŒã¯ç±³åœç¹èš±ç¬¬3718447å·ããã³ç±³åœç¹èš±
第3657237å·ã«é瀺ãããé©åœãªèª¬æãå¿ èŠãšã
ãç¯å²ãŸã§ã¯åèæç®ã«ãã€ãŠããã«åå ¥ããã
ãããªããµãŸãªãžã³éå±å¡©ã¯å¯Ÿå¿ããããããã·
ã¡ãã«ãªããµãŸãªãžã³ãšé©åœéã®ã¢ã«ã«ãªå¡©åºå
å¿ç©ãšã®åå¿ã«ãã€ãŠéåžžã®æ¹æ³ã§è£œé ãããã
ããããªãããã®åå¿ã¯ããã«å¥œéœåã«K2CO3ã
ã¢ã«ã«ãªéå±ã¢ã«ã³ããµã€ããäŸãã°ïŒ«ââ
ïŒâCH3ïŒ3ãæ°ŽçŽ åãããªãŠã ãææ©ãªããŠã ãäŸ
ãã°ããšãã«ãªããŠã ãïœâããã«ãªããŠã ããª
ããŠã ãžã€ãœãããã«ã¢ããçã®å¥œé©ãªå¡©åºã®å
åšäžããªããµãŸãªãžã³ã åŒããããªãžã³ãšåå¿ãããããšã«ãã€ãŠã¢
ã«ã«ãªéå±ãªããµãŸãªãžã³å¡©ïŒåŒïŒã®çŸå Žã§ã®
çæã§å®æœãããã ã«ãããªã³ã°åå¿ã¯çŽïŒã100âã®ç¯å²ã®æž©åºŠ
ã§å®æœããããçŽ10ã50âã®æž©åºŠç¯å²ã奜ãŸã
ããåå¿ã¯äžè¬ã«æº¶åªäžã§å®æœãããããããã
奜é©ãªæº¶åªã䜿çšããããæçšãªæº¶åªã®å ·äœäŸã¯
ãžãªããµã³ããã«ãšã³ãããã©ããããã©ã³ããž
ã¡ãã«ãã«ã ã¢ããããžã¡ãã«ã¹ã«ãããµã€ãã
ãããµã¡ãã«ãã¹ãã«ã¢ãããïœâãã¿ããŒã«ã
ã¢ã»ãã³ãã¢ã«ã«ããŒã«çã§ãããå æ°Žå解ã¯é
åžžã®é žå æ°Žå解詊è¬ãšæè¡äŸãã°CH3COOHã
HClãŸãã¯H2SO4ã®ãããªãããã奜é©ãªé žæº¶æ¶²
åŠçã䜿çšããŠè¡ãªããããå æ°Žå解çæç©ã¯ã
çŽæ¥ãå æ°Žå解çšã«äœ¿çšãããé žã®å¡©ãšããŠåŸã
ãããéäŸçæç©ã¯å¡©ã®éåžžã®äžååŸéé¢å¡©åºãš
ããŠååãããã ã«ãããªã³ã°åå¿ã¯éäŸå€§æ°å§ã§å®æœãããã
åžæãããªãã°é«å§ã䜿çšãããã ã©ã»ããªããµãŸãªãžã³ïŒåŒãŸãã¯ïŒžãåå¿ç©
ãšããŠäœ¿çšãããå Žåãçæç©ã¯ã©ã»ãååç©ãš
ããŠåŸããããã©ã»ãååç©ã¯éåžžã®åå²æè¡ã«
ãã€ãŠåã ã®ãšãã³ããªããŒã«åé¢ããããšãã§
ããã ãªããµãŸãªãžã³ïŒäŸãã°åŒããŸãã¯ïŒã®
Râ²ãæ°ŽçŽ ä»¥å€ã®ãã®ã§ããå ŽåããªããµãŸãªãž
ã³ã®ïŒã®äœçœ®ã§ã®ãã©ã«äžå¿ã«å ããŠïŒã®äœçœ®ã®
第äºã®ãã©ã«äžå¿ããããããããªããµãŸãªãžã³
ãäŸãã°ïŒïŒ³ïŒãïŒïŒ²ïŒãŸãã¯ïŒïŒ²ãïŒãšããŠç€º
ãããæã«ã¯ãã®èšå·ã¯åã«ïŒã®äœçœ®ã®ççŽ åå
ã®ãŸããã®å åŠçé 眮ã«èšåãããã äžèšã®åå¿ã«ãããåŒãŸãã¯ãªããµãŸãªãž
ã³ã®åäžå åŠç°æ§äœã䜿çšããããšã«ãã€ãŠãã
ããªãžã³çæç©ã¯åäžã®ãšãã³ããªããŒãšããŠçŽ
æ¥åŸãããšãã§ãããåŸã€ãŠãªããµãŸãªãžã³ã®ïŒ³
âç°æ§äœã䜿çšããããªãã°ãã®æåŸãããçæ
ç©ã¯ïŒ³âç°æ§äœã§ãããããã¯æ¬çºæã®ããããª
ãžã³é¡ã®åã ã®ç°æ§äœãçŽæ¥è£œé ããããã®éåžž
ã®æ段ãæäŸããã ãæ°ŽçŽ ä»¥å€ã®ãã®ã§ããããããªãžã³é¡ã¯é
åžžããæ°ŽçŽ ã§ããçžåœããååç©ãã¢ã·ã«ãã©
ã€ãäŸãã°ãŠã³ãã«ãã€ã«ã¯ãã©ã€ãããããã€
ã«ã¯ãã©ã€ãããã³ãŸã€ã«ã¯ãã©ã€ããïœâã¡ã
ãã·ãã³ãŸã€ã«ã¯ãã©ã€ããç¡æ°Žç©äŸãã°é ¢é žç¡
æ°Žç©çã®ãããªé©åãªã¢ã·ã«åå€ãšåŠçããããš
ã«ãã€ãŠè£œé ããããåå¿ã¯æ¬¡ã®åŒã«ãã€ãŠèª¬æ
ãããïŒ ãŸãæ¬çºæã®ååç©ã¯æ°èŠãªããããªãžã³é¡ã®
補è¬äžèªããããå¡©ãå å«ããããããã®å¡©ã¯äŸ
ãã°äžè¬ã«å¥œé©ãªæº¶åªäžããããªãžã³ãé©åœéã®
æçšãªå¡©ãšåŠçããããšã«ãã€ãŠé垞補é ãã
ãã ããçš®ã®ä»ã®çœ®æäœãæããããããªãžã³é¡ã
補é ããè¿œå ã®æ¹æ³ã¯æ¬¡ã®åŒé åºã«ãã€ãŠèª¬æã
ãããéåžžã®åå¿æ¡ä»¶ã䜿çšãããã æäœïŒ æäœïŒ ã¢ã«ãã«ã¹ã«ãã€ãã«ãŸãã¯ã¢ã«ãã«ã¹ã«ãã
ã«çœ®æåºãæããããããªãžã³é¡ã¯å¯Ÿå¿ããC1
âC6ã¢ã«ãã«ããªå«æååç©ãé žåããããšã«
ãã€ãŠè£œé ãããããããã奜é©ãªé žåå€äŸãã°
H2O2ã䜿çšãããã次ã®åŒã¯åå¿ã瀺ãã ããçš®ã®ããããªãžã³äžéäœã¯æ¬¡ã®åå¿é åºã«
ãã€ãŠèª¬æãããæ¹æ³ã䜿çšããŠè£œé ããããé
åžžã®æäœããã³è©Šè¬ã䜿çšãããã æäœïŒ¡ æäœïŒ¢ æäœïŒ£ æäœïŒ€ æ¬çºæã®ååç©ã¯æ¥æ§åæã®æé«è¡å§æŽ»æ§ãæ
ããŸãβâã¢ãã¬ããªã³æ§é®æå€ã§ããããã®æ
è¡å§æŽ»æ§ã¯Î²âã¢ãã¬ããªã³é®æã«çŽæ¥é¢ä¿ããª
ãæ©æ§ãçµãŠæ«æ¢¢è¡ç®¡æ¡åŒµãçãããšèããã
ããæ¬çºæã®ããããªãžã³é¡ãéåžžã®Î²âã¢ãã¬
ããªã³å€ä»¥äžã§ããäžã€ã®å©ç¹ã¯æé«è¡å§å¹æã
çŽæ¥ã§ããäžè¬ã«å»¶é·æéã§ããããšã«ããã ãã®æ¥æ§åææé«è¡å§æŽ»æ§ã¯æ¬çºæã®ä»£è¡šçãª
ååç©ãèªçºæ§é«è¡å§ïŒSHïŒã©ããã«æäžãè¡
å§ã§å¹æã枬å®ããããšã«ãã€ãŠåå®ããããã
ã®è©Šéšæ¹æ³ãçšããŠä»£è¡šçãªããããªãžã³ãçµå£
çã«æäžãããæçŽæ¥åæã®ãã®æé«è¡å§æŽ»æ§ã
æããããšãèŠåºãããã æ¬çºæã®Î²âã¢ãã¬ããªã³æ§é®æ掻æ§ã¯çäœå
ã§å¿æ¶åºŠæ°å¢å ãäœè¡å§ããã³æ°ç®¡æ¯æ¡åŒµã®ãã
ãªÎ²âã¢ãã¬ããªã³æ§è奮å¹æãæžããã€ãœãã
ãã¬ããŒã«ããããã¯ãã代衚çãªååç©ã®èœå
ã枬å®ããããšã«ãã€ãŠåå®ãããã代衚çãªã
ãããªãžã³ã¯ãã®çäœå è©ŠéšæäœãçšããŠÎ²âã¢
ãã¬ããªã³æ§é®æ掻æ§ãæããããšãæ瀺ãã
ãã SHã©ããäžã®è¡å§ãæ¥æ¿ã«æžããæ¬çºæã®ã
ãããªãžã³é¡ã®èœåã¯æ¬çºæã®ååç©ãããã®é«
è¡å§çãæ²»çããã®ã«æçšã§ããããšã瀺ãããŸ
ãβâã¢ãã¬ããªã³æ§é®æ掻æ§ã芳å¯ããããã
ãã®ååç©ã¯ããããçå¿æ§ãäžæŽèçã®ãããª
å¿èè¡ç®¡çç¶ãæ²»çããβâã¢ãã¬ããªã³æ§é®æ
å€ãšããŠããã«æçšã§ããããšã瀺ãã æé«è¡å§ããã³ïŒãŸãã¯Î²âã¢ãã¬ããªã³æ§é®
æå€ãšããŠã®çšéãšããŠæ¬çºæã®ååç©ã¯çµå£ç
ã«ãŸãã¯éçµå£çã«å³ã¡éèå ãè ¹è å çã§ãã
ãŠãããã奜çãªçšé圢æ ã§æäžãããããšãã§
ãããååç©ã¯(1)çµå£æäžãšããŠäŸãã°ã¿ã«ã¯ã
æ€ç©æ²¹ãããªãªãŒã«ããã³ãžã«ã¢ã«ã³ãŒã«ããã³
ãã³ãã°ãªã»ãªã³çæ £äŸäžçšããããâãŸãã¯å¥œ
é©ãªæ¶²ç¶æ äœäžã«æº¶è§£ãåæ£ãŸãã¯ä¹³åããâä»
ã®æ··åæåïŒåžéå€ãŸãã¯æ äœïŒãšçµåãããé
å€ãšããŠãŸãã¯ã«ãã»ã«å€ã§ãŸãã¯å¥œé©ãªã«ãã»
ã«åææã§ã«ãã»ã«åããçµå£æäžãšããŠãŸãã¯
(2)奜é©ãªæ¶²ç¶æ äœãŸãã¯åžéå€äžã«æº¶è§£ãåæ£ãŸ
ãã¯ä¹³åããéçµå£æäžãšããŠã®åœ¢æ ã§æäŸãã
ãããšãã§ããã掻æ§æåïŒæ¬çºæã®ããããªãž
ã³ïŒã®æ··åæåã«å¯Ÿããå²åã¯çšé圢æ ãšããŠå€
åãè¬åŠçå¹æãå¿ èŠã§ãããéåžžã®æäœã補è¬
åŠæ¹ã調補ããããã«äœ¿çšãããã æ¬çºæã®ååç©ã«å¯ŸããïŒæ¥ã®çšéã¬ãã«ã¯äœ
éïŒKgåœãçŽ0.02ã50mgã§å€åããããšãã§ã
ããçŽ0.05ã25mg/Kgã®ç¯å²ã®æ¥çšéã奜ãŸã
ããçŽ0.1ã15mg/Kgãããã«å¥œãŸããç¯å²ã§ã
ããäžåãŸãã¯è€æ°åã®æ¥çšéããããåäœæçš
éã«äŸåããŠæäžããããšãã§ããã åŸã€ãŠæ¬çºæã®ä»ã®å ·äœäŸã¯æ¬çºæã®æ²»çäžæ
å¹ãªéã®ååç©ãå«æãã補è¬çµæç©ã§ããã 次ã®å®æœäŸã¯æ¬çºæã®ä»£è¡šçãªããããªãžã³é¡
ã®è£œé ã説æãããã®ã§ãããéšã¯ãã¹ãŠç¹ã«ã
ãšãããªãéãéééšã§ããã枩床ã¯ãã¹ãŠâã§
ãããæ¬çºæã®ããããªãžã³ã®è£œé ã«æçšãªãã
ã€ãã®äžéäœã¯ããŠãšã¹çJ.Med.Chem.第16å·»ã
第849â853é ïŒ1973幎ïŒã«é瀺ãããã å®æœäŸ ïŒ ïŒ¡ ïŒâããããã·âïŒâã·ã¢ãâïŒã»ïŒâãã
ããªãžã³ ïŒâã¢ãããã³ãã³ã¢ã«ãããïŒ2.44ïœã
0.02ã¢ã«ïŒããšãã«Î±âã·ã¢ãã¢ã»ããŒã
ïŒ4.52ïœã0.04ã¢ã«ïŒãç¡æ°Žãšã¿ããŒã«ïŒ50mlïŒ
ããã³ãããªãžã³ïŒ0.5mlïŒã®æ··å液ãéæµäž
ã«æ¹æãããïŒæéåŸæº¶æ¶²ãïŒãïŒâã«å·åŽã
ããé»è²åºäœãéã也ç¥ããŠïŒâããããã·
âïŒâã·ã¢ãâïŒã»ïŒâããããªãžã³ãm.
p.300â2.5ïœïŒ73ïŒ ïŒãçæããã  ïŒâã¯ããâïŒâã·ã¢ãâïŒã»ïŒâããããª
ãžã³ å¡©åãªã³ïŒ12.2ïœã0.059ã¢ã«ïŒãªãã·å¡©å
ãªã³ïŒ44mlïŒããã³ïŒâããããã·âïŒâã·ã¢
ãâïŒã»ïŒâããããªãžã³ïŒ2.3ïœã0.013ã¢
ã«ïŒã®æ··å液ãç°æµäžã«æ¹æãããïŒæéåŸé
å°ã®ãªãã·å¡©åãªã³ãæžå§äžïŒ20ã30mmïŒçå»
ãããæ®æž£ãæ°·ã§åŠçã溶液ãåºäœNa2CO3ã§
äžåããã氎溶液ãCHCl3ïŒïŒÃ100mlïŒã§æœ
åºãããææ©æœåºç©ãNa2SO4ã§ä¹Ÿç¥ããé
ããŠæ¿çž®ä¹Ÿåºãããæ®æž£ã140ã150âã0.3mm
ã§æè¯ãïŒâã¯ããâïŒâã·ã¢ãâïŒã»ïŒâã
ãããªãžã³m.p.273â1.2ïœïŒ81ïŒ ïŒãçæã
ãã  ïŒïŒ³ïŒïŒâã·ã¢ãâïŒâïŒïŒâïœâããã«ã¢
ããâïŒâããããã·ããããã·ïŒâïŒã»ïŒâ
ããããªãžã³ N2äžã也ç¥ãã©ã¹ã³ã«ïŒïŒ³ïŒâïŒâããšãã«
âïŒâããã«ã¢ããâïŒâããããã·ã¡ãã«ãª
ããµãŸãªãžã³ïŒ2.4ïœã0.01ã¢ã«ïŒããžã¡ãã«ã
ã«ã ã¢ããïŒ15mlïŒããã³NaHïŒ50ïŒ é±ç©æ²¹
0.5ïœã0.01ã¢ã«ïŒãå ¥ãæ··å液ãèžæ°æµŽäžã«
ïŒåéå ç±ããã宀枩ã«å·åŽåŸïŒâã¯ããâïŒ
âã·ã¢ãâïŒã»ïŒâããããªãžã³ïŒ1.89ïœã
0.01ã¢ã«ïŒãæ·»å ã溶液ã宀枩ã§æ¹æãããäž
æ©äžæ¹æåŸãæ··å液ãH2OïŒ200mlïŒã«æ³šå ¥ã
ãšãŒãã«ïŒïŒÃ100mlïŒã§æœåºãããææ©çžã
H2OïŒïŒÃ50mlïŒããã³å·1N HClïŒïŒÃ100
mlïŒã§æŽæµãããé žçžãNaOAcã»3H2OïŒ17
ïœã0.2ã¢ã«ïŒã«æ³šå ¥ã溶液ã宀枩ã§æ¹æã
ããïŒæéåŸæº¶æ¶²ããšãŒãã«ïŒïŒÃ75mlïŒã§æœ
åºãããæ°Žçžã飜åNa2CO3ã§äžåãCHCl3
ïŒïŒÃ100mlïŒã§æœåºãããææ©çžãNa2SO4ã§
也ç¥ããéãæ¿çž®ä¹Ÿåºãããæ®æž£ãCH3CN
ã§çµæ¶ããïŒïŒ³ïŒïŒâã·ã¢ãâïŒâïŒïŒâïœâ
ããã«ã¢ããâïŒâããããã·ããããã·ïŒâ
ïŒã»ïŒâããããªãžã³ãm.p.152ãïŒâ0.85
ïŒ20ïŒ ïŒãçæããã å®æœäŸïŒæ®µéã«ãããïŒâã¯ããâïŒâã·ã¢
ãâïŒã»ïŒâããããªãžã³ã®ä»£ããã«ïŒâã¯ãã
âïŒâã·ã¢ãâïŒã»ïŒâããããªãžã³ã䜿çšããŠ
ïŒïŒ³ïŒïŒâã·ã¢ãâïŒâïŒïŒâïœâããã«ã¢ããâ
ïŒâããããã·ããããã·ïŒâïŒã»ïŒâããããª
ãžã³ãåŸãã å®æœäŸ ïŒ ïŒïŒ³ïŒïŒâã·ã¢ãâïŒâïŒïŒâïœâããã«ã¢ãã
âïŒâããããã·ããããã·ïŒâïŒã»ïŒâãã
ããªãžã³ãžãããã¯ããªã N2äžä¹Ÿç¥ãã©ã¹ã³ã«ïŒïŒ³ïŒïŒâããšãã«âïŒ
âïœâããã«ã¢ããâïŒâããããã·ã¡ãã«ãªã
ãµãŸãªãžã³ïŒïŒïœã0.07ã¢ã«ïŒãDMFïŒ25mlïŒã
ãã³NaHïŒ50ïŒ é±ç©æ²¹0.85ïœã0.018ã¢ã«ïŒãå ¥
ãèžæ°æµŽäžã§ïŒåéå ç±ããã宀枩ã«å·åŽåŸïŒâ
ã¯ããâïŒâã·ã¢ãâïŒã»ïŒâããããªãžã³
ïŒ3.3ïœã0.017ã¢ã«ïŒãæ·»å ãæ··å液ã宀枩ã§æ¹
æãããäžæ©äžæ¹æããåŸãæ··å液ãH2OïŒ200
mlïŒã«æ³šå ¥ãããšãŒãã«ïŒïŒÃ100mlïŒã§æœåºã
ããææ©çžãH2OïŒïŒÃ50mlïŒããã³å·1N HCl
ïŒïŒÃ100mlïŒã§æŽæµãããé žçžãNaOAcã»3H2O
ïŒ27ïœã0.2ã¢ã«ïŒã«æ³šã溶液ããšãŒãã«ïŒïŒÃ75
mlïŒã§æœåºãããæ°Žçžã飜åNa2CO3ã§äžåã
CHCl3ïŒïŒÃ100mlïŒã§æœåºãããæ°ŽçžãNa2SO4
ã§ä¹Ÿç¥ãéããŠæ¿çž®ä¹Ÿåºãããæ®æž£ãã·ãªã«ã²
ã«60ã§ã¯ãããã°ã©ããçæç©ãæ°Žæ§NH3ã§é£œå
ããCHCl3ã§æº¶è§£ãããç²çæç©ãã¡ã¿ããŒã«æ§
HClãšã€ãœãããããŒã«ïŒIPAïŒããçµæ¶ãã
ïŒïŒ³ïŒïŒâã·ã¢ãâïŒïŒïŒâïœâããã«ã¢ããâ
ïŒâããããã·ããããã·ïŒâïŒã»ïŒâããããª
ãžã³ãžãããã¯ããªãm.p.215ã17â0.32ïœïŒïŒ
ïŒ ïŒãçæããã å®æœäŸïŒã®ïŒïŒ³ïŒïŒâããšãã«âïŒâïœâãã
ã«ã¢ããâïŒâããããã·ã¡ãã«ãªããµãŸãªãžã³
ã®ä»£ããã«ïŒïŒ²ã»ïŒ³ïŒïŒâã¡ãã«âïŒâã€ãœãã
ãã«ã¢ããâïŒâããããã·ã¡ãã«ãªããµãŸãªãž
ã³ã䜿çšããŠïŒïŒ²ã»ïŒ³ïŒïŒâã·ã¢ãâïŒâïŒïŒâ
ã€ãœãããã«ã¢ããâïŒâããããã·ãããã
ã·ïŒïŒã»ïŒâããããªãžã³ã®ãžãããã¯ããªãã
åŸãã å®æœäŸ ïŒ ïŒïŒ³ïŒïŒâïŒïŒâïœâããã«ã¢ããâïŒâããã
ãã·ããããã·ïŒâïŒã»ïŒâããããªãžã³ãã€
ãããžãšã³ãã¬ãŒãå¡© N2äžä¹Ÿç¥ãã©ã¹ã³ã«ïŒïŒ³ïŒâïŒâããšãã«âïŒ
âïœâããã«ã¢ããâïŒâããããã·ã¡ãã«ãªã
ãµãŸãªã·ã³ïŒ2.5ïœã0.01ã¢ã«ïŒãïœâãã¿ããŒã«
ïŒ50mlïŒãã«ãªãŠã ïœâããããµã€ãïŒ1.3ïœã
0.011ã¢ã«ïŒããã³ïŒâã¯ããâïŒã»ïŒâããã
ãªãžã³ïŒ1.67ïœã0.01ã¢ã«ïŒãå ¥ãæ¹æããªãã
40âã§å ç±ããã15æéåŸæº¶æ¶²ãæ¿çž®ä¹Ÿåºããã
é ¢é žïŒ7.2ïœã0.12ã¢ã«ïŒããã³H2OïŒ120mlïŒã
æ®æž£ã«æ·»å ã溶液ã宀枩ã§æ¹æãããïŒæéåŸæº¶
液ããšãŒãã«ïŒïŒÃ100mlïŒã§æœåºãããæ°Žçžã
飜åNa2CO3ã§äžåããCHCl3ïŒïŒÃ100mlïŒã§æœ
åºãããææ©çžãNa2SO4ã§ä¹Ÿç¥ããéããŠæ¿
瞮也åºãããæ®æž£ãã·ãªã«ã²ã«60ã§ã¯ãããã°ã©
ããçæç©ã20ïŒ MeOHâCHCl3ã§æº¶é¢ãããç²
çæç©ãIPAäžã§ãã¬ã€ã³é žã§çµæ¶ããïŒïŒ³ïŒïŒ
âïŒïŒâïœâããã«ã¢ããâïŒâããããã·ãã
ããã·ïŒâïŒã»ïŒâããããªãžã³ãã€ãããžãšã³
ãã¬ãšãŒãå¡©m.p.117âïŒâ0.4ïœïŒ10ïŒ ïŒãçæ
ããã
ãªãŒã«æ®åºã§ãããïŒãæ°ŽçŽ ã§ãããªããµãŸãªãž
ã³é¡ã補é ããæ¹æ³ïŒããã³é¢é£ããã«ãããªã³
ã°åå¿ïŒã¯ç±³åœç¹èš±ç¬¬3718447å·ããã³ç±³åœç¹èš±
第3657237å·ã«é瀺ãããé©åœãªèª¬æãå¿ èŠãšã
ãç¯å²ãŸã§ã¯åèæç®ã«ãã€ãŠããã«åå ¥ããã
ãããªããµãŸãªãžã³éå±å¡©ã¯å¯Ÿå¿ããããããã·
ã¡ãã«ãªããµãŸãªãžã³ãšé©åœéã®ã¢ã«ã«ãªå¡©åºå
å¿ç©ãšã®åå¿ã«ãã€ãŠéåžžã®æ¹æ³ã§è£œé ãããã
ããããªãããã®åå¿ã¯ããã«å¥œéœåã«K2CO3ã
ã¢ã«ã«ãªéå±ã¢ã«ã³ããµã€ããäŸãã°ïŒ«ââ
ïŒâCH3ïŒ3ãæ°ŽçŽ åãããªãŠã ãææ©ãªããŠã ãäŸ
ãã°ããšãã«ãªããŠã ãïœâããã«ãªããŠã ããª
ããŠã ãžã€ãœãããã«ã¢ããçã®å¥œé©ãªå¡©åºã®å
åšäžããªããµãŸãªãžã³ã åŒããããªãžã³ãšåå¿ãããããšã«ãã€ãŠã¢
ã«ã«ãªéå±ãªããµãŸãªãžã³å¡©ïŒåŒïŒã®çŸå Žã§ã®
çæã§å®æœãããã ã«ãããªã³ã°åå¿ã¯çŽïŒã100âã®ç¯å²ã®æž©åºŠ
ã§å®æœããããçŽ10ã50âã®æž©åºŠç¯å²ã奜ãŸã
ããåå¿ã¯äžè¬ã«æº¶åªäžã§å®æœãããããããã
奜é©ãªæº¶åªã䜿çšããããæçšãªæº¶åªã®å ·äœäŸã¯
ãžãªããµã³ããã«ãšã³ãããã©ããããã©ã³ããž
ã¡ãã«ãã«ã ã¢ããããžã¡ãã«ã¹ã«ãããµã€ãã
ãããµã¡ãã«ãã¹ãã«ã¢ãããïœâãã¿ããŒã«ã
ã¢ã»ãã³ãã¢ã«ã«ããŒã«çã§ãããå æ°Žå解ã¯é
åžžã®é žå æ°Žå解詊è¬ãšæè¡äŸãã°CH3COOHã
HClãŸãã¯H2SO4ã®ãããªãããã奜é©ãªé žæº¶æ¶²
åŠçã䜿çšããŠè¡ãªããããå æ°Žå解çæç©ã¯ã
çŽæ¥ãå æ°Žå解çšã«äœ¿çšãããé žã®å¡©ãšããŠåŸã
ãããéäŸçæç©ã¯å¡©ã®éåžžã®äžååŸéé¢å¡©åºãš
ããŠååãããã ã«ãããªã³ã°åå¿ã¯éäŸå€§æ°å§ã§å®æœãããã
åžæãããªãã°é«å§ã䜿çšãããã ã©ã»ããªããµãŸãªãžã³ïŒåŒãŸãã¯ïŒžãåå¿ç©
ãšããŠäœ¿çšãããå Žåãçæç©ã¯ã©ã»ãååç©ãš
ããŠåŸããããã©ã»ãååç©ã¯éåžžã®åå²æè¡ã«
ãã€ãŠåã ã®ãšãã³ããªããŒã«åé¢ããããšãã§
ããã ãªããµãŸãªãžã³ïŒäŸãã°åŒããŸãã¯ïŒã®
Râ²ãæ°ŽçŽ ä»¥å€ã®ãã®ã§ããå ŽåããªããµãŸãªãž
ã³ã®ïŒã®äœçœ®ã§ã®ãã©ã«äžå¿ã«å ããŠïŒã®äœçœ®ã®
第äºã®ãã©ã«äžå¿ããããããããªããµãŸãªãžã³
ãäŸãã°ïŒïŒ³ïŒãïŒïŒ²ïŒãŸãã¯ïŒïŒ²ãïŒãšããŠç€º
ãããæã«ã¯ãã®èšå·ã¯åã«ïŒã®äœçœ®ã®ççŽ åå
ã®ãŸããã®å åŠçé 眮ã«èšåãããã äžèšã®åå¿ã«ãããåŒãŸãã¯ãªããµãŸãªãž
ã³ã®åäžå åŠç°æ§äœã䜿çšããããšã«ãã€ãŠãã
ããªãžã³çæç©ã¯åäžã®ãšãã³ããªããŒãšããŠçŽ
æ¥åŸãããšãã§ãããåŸã€ãŠãªããµãŸãªãžã³ã®ïŒ³
âç°æ§äœã䜿çšããããªãã°ãã®æåŸãããçæ
ç©ã¯ïŒ³âç°æ§äœã§ãããããã¯æ¬çºæã®ããããª
ãžã³é¡ã®åã ã®ç°æ§äœãçŽæ¥è£œé ããããã®éåžž
ã®æ段ãæäŸããã ãæ°ŽçŽ ä»¥å€ã®ãã®ã§ããããããªãžã³é¡ã¯é
åžžããæ°ŽçŽ ã§ããçžåœããååç©ãã¢ã·ã«ãã©
ã€ãäŸãã°ãŠã³ãã«ãã€ã«ã¯ãã©ã€ãããããã€
ã«ã¯ãã©ã€ãããã³ãŸã€ã«ã¯ãã©ã€ããïœâã¡ã
ãã·ãã³ãŸã€ã«ã¯ãã©ã€ããç¡æ°Žç©äŸãã°é ¢é žç¡
æ°Žç©çã®ãããªé©åãªã¢ã·ã«åå€ãšåŠçããããš
ã«ãã€ãŠè£œé ããããåå¿ã¯æ¬¡ã®åŒã«ãã€ãŠèª¬æ
ãããïŒ ãŸãæ¬çºæã®ååç©ã¯æ°èŠãªããããªãžã³é¡ã®
補è¬äžèªããããå¡©ãå å«ããããããã®å¡©ã¯äŸ
ãã°äžè¬ã«å¥œé©ãªæº¶åªäžããããªãžã³ãé©åœéã®
æçšãªå¡©ãšåŠçããããšã«ãã€ãŠé垞補é ãã
ãã ããçš®ã®ä»ã®çœ®æäœãæããããããªãžã³é¡ã
補é ããè¿œå ã®æ¹æ³ã¯æ¬¡ã®åŒé åºã«ãã€ãŠèª¬æã
ãããéåžžã®åå¿æ¡ä»¶ã䜿çšãããã æäœïŒ æäœïŒ ã¢ã«ãã«ã¹ã«ãã€ãã«ãŸãã¯ã¢ã«ãã«ã¹ã«ãã
ã«çœ®æåºãæããããããªãžã³é¡ã¯å¯Ÿå¿ããC1
âC6ã¢ã«ãã«ããªå«æååç©ãé žåããããšã«
ãã€ãŠè£œé ãããããããã奜é©ãªé žåå€äŸãã°
H2O2ã䜿çšãããã次ã®åŒã¯åå¿ã瀺ãã ããçš®ã®ããããªãžã³äžéäœã¯æ¬¡ã®åå¿é åºã«
ãã€ãŠèª¬æãããæ¹æ³ã䜿çšããŠè£œé ããããé
åžžã®æäœããã³è©Šè¬ã䜿çšãããã æäœïŒ¡ æäœïŒ¢ æäœïŒ£ æäœïŒ€ æ¬çºæã®ååç©ã¯æ¥æ§åæã®æé«è¡å§æŽ»æ§ãæ
ããŸãβâã¢ãã¬ããªã³æ§é®æå€ã§ããããã®æ
è¡å§æŽ»æ§ã¯Î²âã¢ãã¬ããªã³é®æã«çŽæ¥é¢ä¿ããª
ãæ©æ§ãçµãŠæ«æ¢¢è¡ç®¡æ¡åŒµãçãããšèããã
ããæ¬çºæã®ããããªãžã³é¡ãéåžžã®Î²âã¢ãã¬
ããªã³å€ä»¥äžã§ããäžã€ã®å©ç¹ã¯æé«è¡å§å¹æã
çŽæ¥ã§ããäžè¬ã«å»¶é·æéã§ããããšã«ããã ãã®æ¥æ§åææé«è¡å§æŽ»æ§ã¯æ¬çºæã®ä»£è¡šçãª
ååç©ãèªçºæ§é«è¡å§ïŒSHïŒã©ããã«æäžãè¡
å§ã§å¹æã枬å®ããããšã«ãã€ãŠåå®ããããã
ã®è©Šéšæ¹æ³ãçšããŠä»£è¡šçãªããããªãžã³ãçµå£
çã«æäžãããæçŽæ¥åæã®ãã®æé«è¡å§æŽ»æ§ã
æããããšãèŠåºãããã æ¬çºæã®Î²âã¢ãã¬ããªã³æ§é®æ掻æ§ã¯çäœå
ã§å¿æ¶åºŠæ°å¢å ãäœè¡å§ããã³æ°ç®¡æ¯æ¡åŒµã®ãã
ãªÎ²âã¢ãã¬ããªã³æ§è奮å¹æãæžããã€ãœãã
ãã¬ããŒã«ããããã¯ãã代衚çãªååç©ã®èœå
ã枬å®ããããšã«ãã€ãŠåå®ãããã代衚çãªã
ãããªãžã³ã¯ãã®çäœå è©ŠéšæäœãçšããŠÎ²âã¢
ãã¬ããªã³æ§é®æ掻æ§ãæããããšãæ瀺ãã
ãã SHã©ããäžã®è¡å§ãæ¥æ¿ã«æžããæ¬çºæã®ã
ãããªãžã³é¡ã®èœåã¯æ¬çºæã®ååç©ãããã®é«
è¡å§çãæ²»çããã®ã«æçšã§ããããšã瀺ãããŸ
ãβâã¢ãã¬ããªã³æ§é®æ掻æ§ã芳å¯ããããã
ãã®ååç©ã¯ããããçå¿æ§ãäžæŽèçã®ãããª
å¿èè¡ç®¡çç¶ãæ²»çããβâã¢ãã¬ããªã³æ§é®æ
å€ãšããŠããã«æçšã§ããããšã瀺ãã æé«è¡å§ããã³ïŒãŸãã¯Î²âã¢ãã¬ããªã³æ§é®
æå€ãšããŠã®çšéãšããŠæ¬çºæã®ååç©ã¯çµå£ç
ã«ãŸãã¯éçµå£çã«å³ã¡éèå ãè ¹è å çã§ãã
ãŠãããã奜çãªçšé圢æ ã§æäžãããããšãã§
ãããååç©ã¯(1)çµå£æäžãšããŠäŸãã°ã¿ã«ã¯ã
æ€ç©æ²¹ãããªãªãŒã«ããã³ãžã«ã¢ã«ã³ãŒã«ããã³
ãã³ãã°ãªã»ãªã³çæ £äŸäžçšããããâãŸãã¯å¥œ
é©ãªæ¶²ç¶æ äœäžã«æº¶è§£ãåæ£ãŸãã¯ä¹³åããâä»
ã®æ··åæåïŒåžéå€ãŸãã¯æ äœïŒãšçµåãããé
å€ãšããŠãŸãã¯ã«ãã»ã«å€ã§ãŸãã¯å¥œé©ãªã«ãã»
ã«åææã§ã«ãã»ã«åããçµå£æäžãšããŠãŸãã¯
(2)奜é©ãªæ¶²ç¶æ äœãŸãã¯åžéå€äžã«æº¶è§£ãåæ£ãŸ
ãã¯ä¹³åããéçµå£æäžãšããŠã®åœ¢æ ã§æäŸãã
ãããšãã§ããã掻æ§æåïŒæ¬çºæã®ããããªãž
ã³ïŒã®æ··åæåã«å¯Ÿããå²åã¯çšé圢æ ãšããŠå€
åãè¬åŠçå¹æãå¿ èŠã§ãããéåžžã®æäœã補è¬
åŠæ¹ã調補ããããã«äœ¿çšãããã æ¬çºæã®ååç©ã«å¯ŸããïŒæ¥ã®çšéã¬ãã«ã¯äœ
éïŒKgåœãçŽ0.02ã50mgã§å€åããããšãã§ã
ããçŽ0.05ã25mg/Kgã®ç¯å²ã®æ¥çšéã奜ãŸã
ããçŽ0.1ã15mg/Kgãããã«å¥œãŸããç¯å²ã§ã
ããäžåãŸãã¯è€æ°åã®æ¥çšéããããåäœæçš
éã«äŸåããŠæäžããããšãã§ããã åŸã€ãŠæ¬çºæã®ä»ã®å ·äœäŸã¯æ¬çºæã®æ²»çäžæ
å¹ãªéã®ååç©ãå«æãã補è¬çµæç©ã§ããã 次ã®å®æœäŸã¯æ¬çºæã®ä»£è¡šçãªããããªãžã³é¡
ã®è£œé ã説æãããã®ã§ãããéšã¯ãã¹ãŠç¹ã«ã
ãšãããªãéãéééšã§ããã枩床ã¯ãã¹ãŠâã§
ãããæ¬çºæã®ããããªãžã³ã®è£œé ã«æçšãªãã
ã€ãã®äžéäœã¯ããŠãšã¹çJ.Med.Chem.第16å·»ã
第849â853é ïŒ1973幎ïŒã«é瀺ãããã å®æœäŸ ïŒ ïŒ¡ ïŒâããããã·âïŒâã·ã¢ãâïŒã»ïŒâãã
ããªãžã³ ïŒâã¢ãããã³ãã³ã¢ã«ãããïŒ2.44ïœã
0.02ã¢ã«ïŒããšãã«Î±âã·ã¢ãã¢ã»ããŒã
ïŒ4.52ïœã0.04ã¢ã«ïŒãç¡æ°Žãšã¿ããŒã«ïŒ50mlïŒ
ããã³ãããªãžã³ïŒ0.5mlïŒã®æ··å液ãéæµäž
ã«æ¹æãããïŒæéåŸæº¶æ¶²ãïŒãïŒâã«å·åŽã
ããé»è²åºäœãéã也ç¥ããŠïŒâããããã·
âïŒâã·ã¢ãâïŒã»ïŒâããããªãžã³ãm.
p.300â2.5ïœïŒ73ïŒ ïŒãçæããã  ïŒâã¯ããâïŒâã·ã¢ãâïŒã»ïŒâããããª
ãžã³ å¡©åãªã³ïŒ12.2ïœã0.059ã¢ã«ïŒãªãã·å¡©å
ãªã³ïŒ44mlïŒããã³ïŒâããããã·âïŒâã·ã¢
ãâïŒã»ïŒâããããªãžã³ïŒ2.3ïœã0.013ã¢
ã«ïŒã®æ··å液ãç°æµäžã«æ¹æãããïŒæéåŸé
å°ã®ãªãã·å¡©åãªã³ãæžå§äžïŒ20ã30mmïŒçå»
ãããæ®æž£ãæ°·ã§åŠçã溶液ãåºäœNa2CO3ã§
äžåããã氎溶液ãCHCl3ïŒïŒÃ100mlïŒã§æœ
åºãããææ©æœåºç©ãNa2SO4ã§ä¹Ÿç¥ããé
ããŠæ¿çž®ä¹Ÿåºãããæ®æž£ã140ã150âã0.3mm
ã§æè¯ãïŒâã¯ããâïŒâã·ã¢ãâïŒã»ïŒâã
ãããªãžã³m.p.273â1.2ïœïŒ81ïŒ ïŒãçæã
ãã  ïŒïŒ³ïŒïŒâã·ã¢ãâïŒâïŒïŒâïœâããã«ã¢
ããâïŒâããããã·ããããã·ïŒâïŒã»ïŒâ
ããããªãžã³ N2äžã也ç¥ãã©ã¹ã³ã«ïŒïŒ³ïŒâïŒâããšãã«
âïŒâããã«ã¢ããâïŒâããããã·ã¡ãã«ãª
ããµãŸãªãžã³ïŒ2.4ïœã0.01ã¢ã«ïŒããžã¡ãã«ã
ã«ã ã¢ããïŒ15mlïŒããã³NaHïŒ50ïŒ é±ç©æ²¹
0.5ïœã0.01ã¢ã«ïŒãå ¥ãæ··å液ãèžæ°æµŽäžã«
ïŒåéå ç±ããã宀枩ã«å·åŽåŸïŒâã¯ããâïŒ
âã·ã¢ãâïŒã»ïŒâããããªãžã³ïŒ1.89ïœã
0.01ã¢ã«ïŒãæ·»å ã溶液ã宀枩ã§æ¹æãããäž
æ©äžæ¹æåŸãæ··å液ãH2OïŒ200mlïŒã«æ³šå ¥ã
ãšãŒãã«ïŒïŒÃ100mlïŒã§æœåºãããææ©çžã
H2OïŒïŒÃ50mlïŒããã³å·1N HClïŒïŒÃ100
mlïŒã§æŽæµãããé žçžãNaOAcã»3H2OïŒ17
ïœã0.2ã¢ã«ïŒã«æ³šå ¥ã溶液ã宀枩ã§æ¹æã
ããïŒæéåŸæº¶æ¶²ããšãŒãã«ïŒïŒÃ75mlïŒã§æœ
åºãããæ°Žçžã飜åNa2CO3ã§äžåãCHCl3
ïŒïŒÃ100mlïŒã§æœåºãããææ©çžãNa2SO4ã§
也ç¥ããéãæ¿çž®ä¹Ÿåºãããæ®æž£ãCH3CN
ã§çµæ¶ããïŒïŒ³ïŒïŒâã·ã¢ãâïŒâïŒïŒâïœâ
ããã«ã¢ããâïŒâããããã·ããããã·ïŒâ
ïŒã»ïŒâããããªãžã³ãm.p.152ãïŒâ0.85
ïŒ20ïŒ ïŒãçæããã å®æœäŸïŒæ®µéã«ãããïŒâã¯ããâïŒâã·ã¢
ãâïŒã»ïŒâããããªãžã³ã®ä»£ããã«ïŒâã¯ãã
âïŒâã·ã¢ãâïŒã»ïŒâããããªãžã³ã䜿çšããŠ
ïŒïŒ³ïŒïŒâã·ã¢ãâïŒâïŒïŒâïœâããã«ã¢ããâ
ïŒâããããã·ããããã·ïŒâïŒã»ïŒâããããª
ãžã³ãåŸãã å®æœäŸ ïŒ ïŒïŒ³ïŒïŒâã·ã¢ãâïŒâïŒïŒâïœâããã«ã¢ãã
âïŒâããããã·ããããã·ïŒâïŒã»ïŒâãã
ããªãžã³ãžãããã¯ããªã N2äžä¹Ÿç¥ãã©ã¹ã³ã«ïŒïŒ³ïŒïŒâããšãã«âïŒ
âïœâããã«ã¢ããâïŒâããããã·ã¡ãã«ãªã
ãµãŸãªãžã³ïŒïŒïœã0.07ã¢ã«ïŒãDMFïŒ25mlïŒã
ãã³NaHïŒ50ïŒ é±ç©æ²¹0.85ïœã0.018ã¢ã«ïŒãå ¥
ãèžæ°æµŽäžã§ïŒåéå ç±ããã宀枩ã«å·åŽåŸïŒâ
ã¯ããâïŒâã·ã¢ãâïŒã»ïŒâããããªãžã³
ïŒ3.3ïœã0.017ã¢ã«ïŒãæ·»å ãæ··å液ã宀枩ã§æ¹
æãããäžæ©äžæ¹æããåŸãæ··å液ãH2OïŒ200
mlïŒã«æ³šå ¥ãããšãŒãã«ïŒïŒÃ100mlïŒã§æœåºã
ããææ©çžãH2OïŒïŒÃ50mlïŒããã³å·1N HCl
ïŒïŒÃ100mlïŒã§æŽæµãããé žçžãNaOAcã»3H2O
ïŒ27ïœã0.2ã¢ã«ïŒã«æ³šã溶液ããšãŒãã«ïŒïŒÃ75
mlïŒã§æœåºãããæ°Žçžã飜åNa2CO3ã§äžåã
CHCl3ïŒïŒÃ100mlïŒã§æœåºãããæ°ŽçžãNa2SO4
ã§ä¹Ÿç¥ãéããŠæ¿çž®ä¹Ÿåºãããæ®æž£ãã·ãªã«ã²
ã«60ã§ã¯ãããã°ã©ããçæç©ãæ°Žæ§NH3ã§é£œå
ããCHCl3ã§æº¶è§£ãããç²çæç©ãã¡ã¿ããŒã«æ§
HClãšã€ãœãããããŒã«ïŒIPAïŒããçµæ¶ãã
ïŒïŒ³ïŒïŒâã·ã¢ãâïŒïŒïŒâïœâããã«ã¢ããâ
ïŒâããããã·ããããã·ïŒâïŒã»ïŒâããããª
ãžã³ãžãããã¯ããªãm.p.215ã17â0.32ïœïŒïŒ
ïŒ ïŒãçæããã å®æœäŸïŒã®ïŒïŒ³ïŒïŒâããšãã«âïŒâïœâãã
ã«ã¢ããâïŒâããããã·ã¡ãã«ãªããµãŸãªãžã³
ã®ä»£ããã«ïŒïŒ²ã»ïŒ³ïŒïŒâã¡ãã«âïŒâã€ãœãã
ãã«ã¢ããâïŒâããããã·ã¡ãã«ãªããµãŸãªãž
ã³ã䜿çšããŠïŒïŒ²ã»ïŒ³ïŒïŒâã·ã¢ãâïŒâïŒïŒâ
ã€ãœãããã«ã¢ããâïŒâããããã·ãããã
ã·ïŒïŒã»ïŒâããããªãžã³ã®ãžãããã¯ããªãã
åŸãã å®æœäŸ ïŒ ïŒïŒ³ïŒïŒâïŒïŒâïœâããã«ã¢ããâïŒâããã
ãã·ããããã·ïŒâïŒã»ïŒâããããªãžã³ãã€
ãããžãšã³ãã¬ãŒãå¡© N2äžä¹Ÿç¥ãã©ã¹ã³ã«ïŒïŒ³ïŒâïŒâããšãã«âïŒ
âïœâããã«ã¢ããâïŒâããããã·ã¡ãã«ãªã
ãµãŸãªã·ã³ïŒ2.5ïœã0.01ã¢ã«ïŒãïœâãã¿ããŒã«
ïŒ50mlïŒãã«ãªãŠã ïœâããããµã€ãïŒ1.3ïœã
0.011ã¢ã«ïŒããã³ïŒâã¯ããâïŒã»ïŒâããã
ãªãžã³ïŒ1.67ïœã0.01ã¢ã«ïŒãå ¥ãæ¹æããªãã
40âã§å ç±ããã15æéåŸæº¶æ¶²ãæ¿çž®ä¹Ÿåºããã
é ¢é žïŒ7.2ïœã0.12ã¢ã«ïŒããã³H2OïŒ120mlïŒã
æ®æž£ã«æ·»å ã溶液ã宀枩ã§æ¹æãããïŒæéåŸæº¶
液ããšãŒãã«ïŒïŒÃ100mlïŒã§æœåºãããæ°Žçžã
飜åNa2CO3ã§äžåããCHCl3ïŒïŒÃ100mlïŒã§æœ
åºãããææ©çžãNa2SO4ã§ä¹Ÿç¥ããéããŠæ¿
瞮也åºãããæ®æž£ãã·ãªã«ã²ã«60ã§ã¯ãããã°ã©
ããçæç©ã20ïŒ MeOHâCHCl3ã§æº¶é¢ãããç²
çæç©ãIPAäžã§ãã¬ã€ã³é žã§çµæ¶ããïŒïŒ³ïŒïŒ
âïŒïŒâïœâããã«ã¢ããâïŒâããããã·ãã
ããã·ïŒâïŒã»ïŒâããããªãžã³ãã€ãããžãšã³
ãã¬ãšãŒãå¡©m.p.117âïŒâ0.4ïœïŒ10ïŒ ïŒãçæ
ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ åŒ ãŸã㯠ãæããååç©ããã³ãã®è£œè¬äžèªããããå¡© ãåŒäžãã¯âCH2âCHOHâCH2âNHR1ã§ãã ïŒåŒäžãR1ã¯C1âC12ã¢ã«ãã«ã§ãããïŒãã ïŒ âCNãâOZåºã«å¯ŸããŠãªã«ãã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé ã®ååç©ã ïŒ R1ãC3âC4åæã¢ã«ãã«ã§ããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé ã®ååç©ã ïŒ R1ãïœâããã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é ã®ååç©ã ïŒ ïŒ³âç°æ§äœé 眮ãæããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é ã®ååç©ã ïŒ åŒ ãæããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã®ååç©ã ïŒ R1ãC3âC4ã¢ã«ãã«ã§ããç¹èš±è«æ±ã®ç¯å²
第ïŒé ã®ååç©ã ïŒ âR1ãïœâããã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé ã®ååç©ã ïŒ ïŒ³âç°æ§äœé 眮ãæããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é ã®ååç©ã ïŒïŒ åŒ ãæããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã®ååç©ã ïŒïŒ R1ãC3-4ã¢ã«ãã«ããã³R2ãâCNã§ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé ã®ååç©ã ïŒïŒ R1ãïœâããã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒïŒé ã®ååç©ã ïŒïŒ âç°æ§äœé 眮ãæããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒïŒé ã®ååç©ã ïŒïŒ åŒ ãæããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã®ååç©ã ïŒïŒ R1ãïœâããã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒïŒé ã®ååç©ã
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79275277A | 1977-05-02 | 1977-05-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS53136000A JPS53136000A (en) | 1978-11-28 |
JPS6115875B2 true JPS6115875B2 (ja) | 1986-04-26 |
Family
ID=25157956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5224978A Granted JPS53136000A (en) | 1977-05-02 | 1978-04-28 | Novel naphthylidines |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS53136000A (ja) |
BE (1) | BE866544A (ja) |
CH (1) | CH634320A5 (ja) |
DE (1) | DE2818290A1 (ja) |
DK (1) | DK166478A (ja) |
FR (1) | FR2389624B1 (ja) |
GB (1) | GB1566693A (ja) |
IE (1) | IE46874B1 (ja) |
IT (1) | IT1107210B (ja) |
LU (1) | LU79551A1 (ja) |
NL (1) | NL7804168A (ja) |
SE (1) | SE7804318L (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233332A (en) * | 1978-03-16 | 1980-11-11 | Firmenich Sa | Use of bicyclic nitrogen-containing derivatives as flavoring ingredients |
DE3169626D1 (en) * | 1981-02-27 | 1985-05-02 | American Home Prod | Antihypertensive agents |
US5240916A (en) * | 1989-07-27 | 1993-08-31 | Dowelanco | Naphthyridine derivatives |
AU634561B2 (en) * | 1989-07-27 | 1993-02-25 | Eli Lilly And Company | Naphthyridine derivatives |
AU2012254158B2 (en) | 2011-02-18 | 2016-02-04 | Medivation Technologies, Inc. | Compounds and methods of treating diabetes |
EP2887805A4 (en) * | 2012-08-22 | 2016-08-17 | Medivation Technologies Inc | COMPOUNDS AND METHOD FOR TREATING BLOOD HIGH PRESSURE |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1006725A (fr) * | 1948-08-31 | 1952-04-28 | Cilag Spa | Nouveaux dérivés de la naphtyridine et procédé pour leur préparation |
GB743901A (en) * | 1952-02-18 | 1956-01-25 | Ward Blenkinsop & Co Ltd | Substituted pyridines and process for the production thereof |
GB745348A (en) * | 1952-03-10 | 1956-02-22 | Howards Ilford Ltd | Basically substituted pyridines and process for the production thereof |
CH581113A5 (ja) * | 1973-10-08 | 1976-10-29 | Sandoz Ag |
-
1978
- 1978-04-17 SE SE7804318A patent/SE7804318L/xx unknown
- 1978-04-17 DK DK166478A patent/DK166478A/da active IP Right Grant
- 1978-04-19 NL NL7804168A patent/NL7804168A/xx not_active Application Discontinuation
- 1978-04-26 IT IT49081/78A patent/IT1107210B/it active
- 1978-04-26 DE DE19782818290 patent/DE2818290A1/de not_active Ceased
- 1978-04-27 GB GB16780/78A patent/GB1566693A/en not_active Expired
- 1978-04-28 LU LU79551A patent/LU79551A1/xx unknown
- 1978-04-28 JP JP5224978A patent/JPS53136000A/ja active Granted
- 1978-04-28 BE BE187252A patent/BE866544A/xx not_active IP Right Cessation
- 1978-04-28 CH CH466778A patent/CH634320A5/de not_active IP Right Cessation
- 1978-05-01 IE IE862/78A patent/IE46874B1/en unknown
- 1978-05-02 FR FR7812935A patent/FR2389624B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IT1107210B (it) | 1985-11-25 |
DE2818290A1 (de) | 1978-11-09 |
JPS53136000A (en) | 1978-11-28 |
BE866544A (fr) | 1978-10-30 |
IE780862L (en) | 1978-11-02 |
CH634320A5 (en) | 1983-01-31 |
IT7849081A0 (it) | 1978-04-26 |
FR2389624A1 (ja) | 1978-12-01 |
GB1566693A (en) | 1980-05-08 |
NL7804168A (nl) | 1978-11-06 |
LU79551A1 (fr) | 1979-02-02 |
IE46874B1 (en) | 1983-10-19 |
SE7804318L (sv) | 1978-11-03 |
DK166478A (da) | 1978-11-03 |
FR2389624B1 (ja) | 1982-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6313137B1 (en) | Imidazo pyridine derivatives which inhibit gastric acid secretion | |
AU723389B2 (en) | Compounds for inhibition of gastric acid secretion | |
US4166851A (en) | Certain imidazo(1,2a)pyridine derivatives | |
US4408047A (en) | Imidazodiazines | |
JPS6115875B2 (ja) | ||
US4176183A (en) | Novel naphthyridines | |
EP0107693A1 (en) | ANALOGUE COMPOUNDS OF 2,3,4-TRINOR-1,5-INTER-M-PHENYLENE-PROSTACYCLINE-I2, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
EP0114572A1 (de) | Substituierte Imidazo(1,5-a)pyridine | |
US4233301A (en) | Novel imidazoazines and imidazodiazines | |
JPS59210085A (ja) | æ°èŠãšã«ãŽãªã³èªå°äœã®è£œé æ³ | |
KR900005470B1 (ko) | íŒëŠ¬ëìí¬ ëìŽíž ë ìŽíž íí©ë¬Œì ì ì¡°ë°©ë² | |
JP2744224B2 (ja) | ãã¹âã¢ã¶âäºç°åŒæäžå®è¬ã®è£œæ³ | |
JPS631308B2 (ja) | ||
US4052404A (en) | Indolo (2,3-α)quinolizines | |
US4330543A (en) | Imidazoazines and imidazodiazines | |
HU192728B (en) | Process for producing 4-oxo-pyrido/2,3-d/pyrimidine derivatives and pharmaceutical compositions containing them | |
JPS6351374A (ja) | ã€ãããŸãŒã«èªå°äœããããã®è£œé æ³åã³è¬å€ãšããŠã®äœ¿çš | |
US4360533A (en) | Glyceryl ester of 1-methyl-2-(3,4-dihydroxyphenyl)alanine | |
WO2001044197A2 (fr) | Derives de 2-phenyl-quinoleine et leur utilisation en tant qu'agent contractant des muscles lisses | |
JPS6330485A (ja) | æ°èŠãªåç°åŒã€ã³ãâã«èªå°äœ | |
JPS5910358B2 (ja) | æ°èŠãšã«ãŽãªã³èªå°äœ | |
JPS5852995B2 (ja) | ãã«ãã©âã«èªå°äœã®è£œé æ³ | |
KR820000493B1 (ko) | íŽë졞늰 ì ë첎ì ì ì¡°ë°©ë² | |
KR790001497B1 (ko) | ì¹í íŒëŠ¬ëë¥ì ì ë² | |
US4251663A (en) | Thiosubstituted pyridines |